Standout Papers
Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Heart Failure and Socioeconomic Status: Accumulating Evidence of Inequality
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Begeleiding verbetert therapietrouw. Apotheker stimuleert correct gebruik lisdiuretica bij patiënten met hartfalen
2003
Associations With and Prognostic Impact of Chronic Kidney Disease in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
2017
Heart Failure: Preventing Disease and Death Worldwide
2014
No health without mental health
2007 Standout
Magnesium in the Central Nervous System
2011
Metaanalysis and review of heart failure disease management randomized controlled clinical trials
2005
Can Health Care Teams Improve Primary Care Practice?
2004
N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure
2010
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Medication Undertreatment in Assisted Living Settings
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure
2008
Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality score
2009
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Effects of Admission to a Teaching Hospital on the Cost and Quality of Care for Medicare Beneficiaries
1999
Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia
2006
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)
2007
History of Depression as a Predictor of Adverse Outcomes in Patients Hospitalized for Decompensated Heart Failure
2004
Is Addition of Vasodilators to Loop Diuretics of Value in the Care of Hospitalized Acute Heart Failure Patients? Real-World Evidence From a Retrospective Analysis of a Large United States Hospital Database
2014
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?
2004
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
1990
Inpatient Initiation of β-blockade Plus Nurse Management in Vulnerable Heart Failure Patients: A Randomized Study
2008
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
2015
Prolonged Emergency Department Length of Stay is not Associated with Worse Outcomes in Patients with Intracerebral Hemorrhage
2011
A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study
2010
Surgeon Volume and Operative Mortality in the United States
2003 Standout
Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest
2001
Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management Study
2002
Pharmaceutical care of patients with heart failure
2005
Smoking is a risk factor in the progression to kidney failure
2011
The role of the kidney in heart failure
2012
Acute kidney injury
2019 Standout
Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure<SUBTITLE>The EVEREST Clinical Status Trials</SUBTITLE>
2007
Treatment of Depression in Patients with Coronary Heart Disease
2006
Interventions used in disease management programmes for patients with chronic illness---which ones work? Meta-analysis of published reports
2002
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
1991
Depression in Heart Failure
2006 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Hospital Volume and Surgical Mortality in the United States
2002 Standout
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials
2014
Myocardial Reperfusion Injury
2007 Standout
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*
2010
Clinical and Economic Effects of Pharmacy Services in a Geriatric Ambulatory Clinic
2000
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review
2004
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study
2003
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
A Systematic Meta-Analysis of the Efficacy and Heterogeneity of Disease Management Programs in Congestive Heart Failure
2006
Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association
2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
2018
Practical Applications of Intravenous Diuretic Therapy in Decompensated Heart Failure
2006
Implementation of a Community Pharmacy–Based Falls Prevention Program
2011
A multicenter disease management program for hospitalized patients with heart failure
2004
Impact of empagliflozin in patients with diabetes and heart failure
2016
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
Real-World Evidence — What Is It and What Can It Tell Us?
2016 Standout
Eficacia de la información al alta en la adherencia del paciente polimedicado
2011
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Multidisciplinary strategies for the management of heart failure patients at high risk for admission
2004 Standout
Adherence to Medication
2005 Standout
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
2009
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension
2011
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
1990
Magnesium in Man: Implications for Health and Disease
2014 Standout
Care management interventions for older patients with congestive heart failure.
2003
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus
2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties
2016 Standout
Part 9: Post–Cardiac Arrest Care
2010 Standout
Diabetic Cardiomyopathy
2018 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Pharmacist Intervention to Improve Medication Adherence in Heart Failure
2007
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction
2013
Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure
2012
Interventions for enhancing medication adherence
2014 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
2003
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
Randomized Trial of Telephone Intervention in Chronic Heart Failure (DIAL): Study design and preliminary observations
2003
Medication Adherence
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Antimicrobial Stewardship Programs in Health Care Systems
2005
Interventions for preventing falls in older people living in the community
2012 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Treatment Performance Measures Affect Clinical Outcomes in Patients With Acute Systolic Heart Failure
2012
Improving the Quality of Measurement and Evaluation in Quality Improvement Efforts
2008
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Cathal O’Connor being referenced
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
2014
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study
2011
Management of acute decompensated heart failure
2007
Magnesium Gluconate Offers No More Protection than Magnesium Sulphate Following Diffuse Traumatic Brain Injury in Rats
2004
Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team
1999
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF
2008
Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized With Heart Failure
2007
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin
2003
Reduction in heart failure events by clinical pharmacist intervention: pharmacist in heart failure assessment recommendation and monitoring (PHARM) study
1998
Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.
1988
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion.
1993
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial
2004